EFFECT - Jin Medical International Ltd. (0001837821) (Filer)

F-3/A - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

F-3 - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

6-K - Jin Medical International Ltd. (0001837821) (Filer)

20-F/A - Jin Medical International Ltd. (0001837821) (Filer)

Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. ("Zhongjin Anhui"), has officially launched production at Plant No. 3 of Zhongjin Anhui's intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing cap

Changzhou City, China, May 06, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ:ZJYL) (the "Company") today announced that on May 2, 2025, it received a deficiency letter (the "Notice") from the Nasdaq Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq"). The Notice informed the Company that, based upon the closing bid price of the Company's ordinary shares ("Ordinary Shares") over the 30 consecutive business day period between March 20, 2025 and May 1, 2025, the Company is not in compliance with the requirement to maintain a minimum bid price of $1.00 per share of its Ordinary Shares for continued listing on The Nasdaq Capital Market, as

Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ:ZJYL), an industrial leader in Assistive Technologies ("AT"), and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMed's new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed (Anhui) Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMed plant (the "New Facility") which is established as an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. With higher-level production l

Changzhou City, China, Dec. 14, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the signing of a preliminary Memorandum of Understanding (MOU) with Jiangsu Zhongjin Kanglu Information Technology Co., Ltd. ("Zhongjin Kanglu") to acquire all or a partial stake in Zhongjin Kanglu. According to the MOU, the Company will conduct a comprehensive due diligence process to evaluate and determine the feasibility and potential value of the acquisition. It is expected that the due diligence will be comp

Changzhou City, China, Dec. 13, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced the Company's portable nano-thermal therapy bath has been selected as the equipment for "Lao Le Hui" Assisted Bathing Project (the "Project"). This significant initiative is a collaborative effort between a recognized foundation for the elderly in Shanghai, prominent state-owned enterprises, and industry partners, with the noble purpose of providing compassionate care and assistance to disabled or semi-disabled elde

Changzhou City, China, Dec. 11, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that it has secured orders of RMB 66 million (approximately $9.18 million USD) of their innovative Micro-Hyperbaric Oxygen Chamber equipment (S-type and M-type) from Conlo Industrial Development (Shanghai) CO., LTD. ("Conlo"). Building on the successful launches of its MINI micro-hyperbaric oxygen chamber and hydrogen generation machine products in this September, JinMed has recently unveiled S-type (accommodating

CHANGZHOU, China, Sept. 28, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("JinMed" or "the Company") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, received a written notification letter ("the Notification Letter") from The NASDAQ Stock Market LLC ("NASDAQ") dated September 25, 2023, notifying the Company that it no longer complies with the requirement of minimum 300 public holders for continued listing as set forth under NASDAQ Listing Rule 5550(a)(3).  The Notification Letter has no immediate effect on the listing of the Company's ordinary shares. Under NASDAQ Listing Rules, the Comp

CHANGZHOU, China, Aug. 31, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ:ZJY) is the world's leading provider of rehabilitation equipment. Recently, JinMed announced it has expand into the field of manufacturing lifestyle beauty products by establishing the Beauty Products Division. The company has collaborated with the renowned Japanese beauty product manufacturer, MIYAKO, to successfully develop three products: "facial management equipment," "slimming fat burning equipment," and "health management equipment." This is the first groundbreaking technology in the world, and it is expected to commence mass production in mid-October. Currently, the produ

CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.Revenues from whee

CHANGZHOU, China, Aug. 17, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), the world's leading provider of rehabilitation equipment, rang the bell at the New York Stock Exchange by its Chairman and CEO Wang Erqi on August 17, to celebrate the Company's official listing. JinMed has been publicly traded on the Nasdaq Capital Market since March 28, 2023. Since its establishment in 2006, JinMed has been committed to providing more comfortable, convenient, and safe products for socially disadvantaged groups. JinMed focuses on R&D and manufacturing high-end rehabilitation equipment. Its products include walking aids, breathing medical equipment, in

CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.Revenues from whee